Democratic Presidential Contenders Have Little To Say On The Subject Of Research

While the five hopefuls have opinions on such matters as education and science funding, their views lack depth WASHINGTON--The five major Democratic contenders for president of the United States generally agree that the country needs to strengthen its technology base, that spending on civilian research should be increased, and that universities remain the key to the nation's scientific preeminence. At the same time, they differ over whether it makes sense to build the superconducting supercol

Written byJeffrey Mervis
| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share

At the same time, they differ over whether it makes sense to build the superconducting supercollider and space station Freedom. In addition, they would reexamine--and possibly reapportion to more pressing domestic needs--the billions of dollars now being spent at the Energy Department's national laboratories.

That assessment is based largely on their replies to a questionnaire drawn up by The Scientist on science and technology policy issues and, to a lesser extent, their public statements or voting records in Congress.

The seven-question survey sought the candidates' views on topics such as indirect costs recovery and precollege science and math education, as well as how they would pay for any new spending proposals.

While those replies provide some clue as to what these men might do on scientific matters after moving into 1600 Pennsylvania Ave., they're not saying much about the subject as they woo voters in Iowa, New Hampshire, and here ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies